Boston Scientific
Article Abstract:
The revenues and profits of Boston Scientific (BSC) are expected to increase dramatically in 2004 and 2005. A comparative analysis of the sales earnings and the financial details from the year 1994-2003 are detailed. Different financial ratios according to the Value Line Publication are given.
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2004
User Contributions:
Comment about this article or add new information about this topic:
C.R. Bard, Inc
Article Abstract:
A comparative analysis of the company sales and financial details of C.R. Bard, Inc. from 1988 to 2003 are illustrated. Projections of the annual total returns, revenues and the assets position of the company for the period 2007-09 are made using value line estimates.
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2004
User Contributions:
Comment about this article or add new information about this topic:
Bard (C.R.), Inc
Article Abstract:
A comparative analysis of the sales earnings and the financial details of C.R. Bard Inc. from the year 1988-2003 are detailed. The company is expected to register 12 percent annual per-share profit gains in the long run.
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2004
User Contributions:
Comment about this article or add new information about this topic: